| Enrolling By Invitation | Comparison of Blended Care Outpatient Neurorehabilitation With Traditional Outpatient Neurorehabilitation NCT07458308 | Luzerner Kantonsspital | N/A |
| Recruiting | Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors NCT07414732 | Massachusetts General Hospital | N/A |
| Not Yet Recruiting | Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrh NCT07243704 | Christian Medical College and Hospital, Ludhiana, India | Phase 3 |
| Recruiting | Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability NCT07053917 | Johns Hopkins University | Phase 1 |
| Recruiting | Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage NCT07208097 | Tongji Hospital | N/A |
| Not Yet Recruiting | NICardipine for Fast Achievement of Systolic BP Targets in ICH NCT07044232 | Aarhus University Hospital | Phase 4 |
| Recruiting | Minimally Invasive Surgery For Patients With Spontaneous Deep Intracerebral Hemorrhage NCT07234955 | Huynh Quoc Huy | — |
| Recruiting | Timing and Outcomes of Recovery After intraCerebral Hemorrhage NCT07166146 | Xuanwu Hospital, Beijing | — |
| Recruiting | Efficacy and Safety of NeuroEndoscopic Surgery for Large IntraCerebral Hemorrhage NCT06894433 | Southwest Hospital, China | N/A |
| Recruiting | AI-assisted Transcranial Duplex Sonography for Early Detection of Intracerebral Haemorrhage: HYPER-AI-SCAN NCT07319013 | Hospital Universitari Vall d'Hebron Research Institute | — |
| Recruiting | International Care Bundle Evaluation in Cerebral Hemorrhage Research NCT06429332 | Region Skane | Phase 4 |
| Not Yet Recruiting | The Planetary Outcomes After Intracranial Haemorrhage Study NCT06731751 | University of Cambridge | — |
| Recruiting | Ischaemic Lesions in Acute Intracerebral Haemorrhage NCT06410274 | University of Leicester | — |
| Recruiting | Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage NCT05369351 | Tianjin Medical University General Hospital | Phase 2 |
| Recruiting | Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage (EMINENT-ICH) NCT05681988 | University Hospital, Basel, Switzerland | N/A |
| Completed | Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Dee NCT06067750 | Nottingham University Hospitals NHS Trust | — |
| Recruiting | Statins for Treatment of Primary Intracerebral Hemorrhage NCT07088250 | The Second Hospital of Anhui Medical University | N/A |
| Recruiting | The EBC Recovery Study NCT04712591 | University of Miami | — |
| Completed | BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage NCT03737344 | Adrian Parry-Jones | Phase 2 |
| Completed | STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke NCT03385928 | Neuroscience Trials Australia | Phase 2 |
| Unknown | Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial NCT03044184 | Kwong Wah Hospital | Phase 3 |
| Completed | ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH) NCT02880878 | Nico Corporation | N/A |
| Completed | Head Position in Stroke Trial (HeadPoST) NCT02162017 | The George Institute | N/A |
| Completed | Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study NCT02176174 | University College, London | — |
| Completed | STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial NCT01702636 | Neuroscience Trials Australia | Phase 2 |
| Unknown | Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber) NCT01947361 | University College, London | — |
| Unknown | Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study NCT01937065 | University College, London | — |
| Unknown | Surgical Trial in Lobar Intracerebral Haemorrhage NCT01320423 | Taipei Medical University WanFang Hospital | N/A |
| Completed | Factor VIIa in Acute Intracerebral Haemorrhage NCT00266006 | Novo Nordisk A/S | Phase 2 |
| Completed | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage NCT00127283 | Novo Nordisk A/S | Phase 3 |
| Completed | Recombinant Factor VIIa in Acute Intracerebral Haemorrhage NCT00426803 | Novo Nordisk A/S | Phase 2 |
| Completed | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII for Preventing Early Hematoma Growth NCT01563445 | Novo Nordisk A/S | Phase 2 |
| Completed | Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage NCT01566786 | Novo Nordisk A/S | Phase 2 |